Cargando…
NSCs are permissive to oncolytic Myxoma virus and provide a delivery method for targeted ovarian cancer therapy
Despite the development of many anticancer agents over the past 20 years, ovarian cancer remains the most lethal gynecologic malignancy. Due to a lack of effective screening, the majority of patients with ovarian cancer are diagnosed at an advanced stage, and only ~20% of patients are cured. Thus, i...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7771716/ https://www.ncbi.nlm.nih.gov/pubmed/33473255 http://dx.doi.org/10.18632/oncotarget.27845 |